Calcipotriene
Back to searchMolecule Structure
Scientific Name
Calcipotriene
Description of the Drug
Calcipotriol is a topical synthetic vitamin D2 derivative used in the treatment of plaque psoriasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB02300
http://www.drugbank.ca/drugs/DB02300
Brand Name(s)
Calcipotriene, Dovobet, Dovonex, Enstilar, Sorilux, Xamiol
Company Owner(s)
Akorn Operating Co Llc, Glenmark Pharmaceuticals Inc Usa, Leo Pharmaceutical Products Ltd, Fougera Pharmaceuticals Inc, Novel Laboratories Inc, Padagis Israel Pharmaceuticals Ltd, Glenmark Pharmaceuticals Sa, Tolmar Inc, Mc2 Therapeutics Ltd, Mayne Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Vitamin D receptor | SINGLE PROTEIN | AGONIST | CHEMBL1977 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2853 | ||||
| Human Metabolome Database | HMDB0015567 | ||||
| DrugBank | DB02300 | ||||
| PubChem: Thomson Pharma | 14855474 | 14855477 | |||
| PubChem | 5288783 | ||||
| LINCS | LSM-42986 | ||||
| Nikkaji | J367.434G | J490.503B | |||
| PDBe | MC9 | ||||
| BindingDB | 50369964 | ||||
| EPA CompTox Dashboard | DTXSID0046648 | ||||
| LipidMaps | LMST03020106 | ||||
| DrugCentral | 465 | ||||
| Brenda | 147213 | ||||
| ChemicalBook | CB1412712 | ||||
| Guide to Pharmacology | 2778 | ||||
| rxnorm | SORILUX | CALCIPOTRIENE | CALCIPOTRIENE HYDRATE | ENSTILAR | DOVONEX |
| PubChem: Drugs of the Future | 12014175 | ||||
| ChEBI | 50749 | ||||
| ZINC | ZINC000003921872 |
